1. Introduction
As visually impaired people cannot obtain visual information about the outside world, they use visual assistive devices such as white canes. However, a white cane cannot always be used with one hand, which could be dangerous in an emergency. Therefore, hands-free visual assistive devices have been researched; however, many devices in research studies block other senses, such as hearing [
1,
2]. Therefore, phosphenes have been researched to provide visual information despite visual impairment [
3,
4].
Phosphenes are flashes of light recognized by electrically stimulating the eyeball and visual cortex. The presentation position of phosphenes can be controlled by adjusting the position of the electrodes on the face [
3,
4,
5]. In terms of stimulating the eyeball, the stimulated area has been discussed in several studies [
3,
6]. Laakso reported that the electric current flows to the retinae along the eye socket using electric simulation when the phosphenes are observed [
6]. However, their hypothesis on the electric current flow is inconsistent with the real observed position of phosphenes reported in several studies. If the electric current flows to the retinae along the eye socket, the phosphene should be observed on the left side of vision when the temporal right eyeball is stimulated. However, several studies have reported that the phosphene was observed on the right side, when the temporal right eyeball was stimulated. Moreover, a previous study has reported that, when the eyeball is moved to the left and right for peripheral vision, the phosphene presentation position was changed because the visual retina on the anterior side may also be exposed and stimulated directly [
3]. The visual retina exposed by eye movements should be stimulated if the electric current flows along the eye socket; however, the observed phosphene position was extremely different from the reported phosphene presentation position [
3,
5]. Therefore, a previous study suggested that the cornea and sclera, which are the eyeball surfaces exposed to the anterior side, and the retina, which is located at the opposite pole of the stimulated area, were stimulated [
3]. Therefore, the phosphene presentation position can be controlled by calibrating the electrode arrangement on the face to stimulate the intended eyeball surface area.
However, when using phosphenes as a walking assistive device for the visually impaired, the position of the phosphenes changes significantly due to eye movement, which is a safety issue for the walking assistive device. Although the electric current does not flow along the eye socket and stimulate the retina, the depth to which facial skin and eyeballs are stimulated by the electric current has not been clarified.
Therefore, in this study, the Hess test was used to gradually move the eyeball and verify how the position of the phosphenes changes in this case. The related works about eye movement during walking were also investigated and the results were compared to discuss the safety of visual assistive devices that use phosphenes. This study clarifies that eye movements during walking do not affect the presentation position of phosphenes. Moreover, this study contributes to clarifying the stimulation depth of the electrical current around the eye.
The rest of the paper is organized as follows:
Section 2 discusses related studies and background knowledge, and the evaluation methods are presented in
Section 3.
Section 4 describes the evaluation results.
Section 5 discusses the results, and the conclusions of this study are presented in
Section 6.
4. Verification of Experimental Results
In this section, the qualitative and quantitative evaluations of the results of the verification experiment are presented. First, the qualitative evaluation is presented.
Figure 7a shows the verification results for electrode arrangement 1, with the phosphene presentation positions of all subjects superimposed. Similarly,
Figure 7b shows the results for electrode arrangement 2,
Figure 7c for electrode arrangement 3, and
Figure 7d for electrode arrangement 4. The numbers 1 to 17 correspond to the fixation points on the Hess chart shown in
Figure 3.
Fixation points 1 to 7 represent a visual field of ±15 deg, 8 to 15 represent a visual field of ±30 deg, 16 represents the case where the eyeball was moved to the left as far as possible, and 17 represents the case where the eyeball was moved to the right as far as possible. The white circles represent the presentation positions of the phosphene drawn by the subjects, and drawing them on the right side of the image means that the phosphene was presented on the right side of the visual field.
Since
Figure 7a was a verification experiment using electrode arrangement 1, phosphenes were generally presented on the right side of the visual field at fixation points 1 to 7. Some subjects appeared to observe phosphenes on the left side of the visual field, because the Ora Serrata inside the eyeball was located closer to the anterior side. The position of the retina inside the eyeball shown in
Figure 1 in
Section 2.1 is based on a previous study [
3], but there are individual differences. Therefore, subjects who observed phosphenes on the left side of the visual field with electrode arrangement 1 would be able to observe them on the right side of the visual field by adjusting the electrode arrangement and stimulating current value. In addition,
Figure 7a shows that, in the verification experiment results for electrode arrangement 1, some subjects observed phosphenes in the center of the visual field. This result also suggests that electrode arrangement 1 may have stimulated the area that was originally intended to be stimulated with electrode arrangement 2. Therefore, it is believed that phosphenes can be presented on the right side of the visual field by adjusting the electrode arrangement position of the relevant subjects.
Figure 7b,c show the results of a verification experiment using electrode arrangements 2 and 3, which present phosphenes in the center of the visual field. These results show that phosphenes were presented approximately near the center of the visual field at fixation points 1 to 7. Because electrode arrangement 2 stimulates the right eyeball and electrode arrangement 3 stimulates the left eyeball, it appears that phosphenes were presented to the right of the center of the visual field when electrode arrangement 2 was used, and to the left of the center of the visual field when electrode arrangement 3 was used. This is because a previous study [
4] reported that it was difficult to stimulate the area near the inner corner of the eye due to the shape of the eye socket. It is speculated that the area from the center of the stimulated eyeball to the outer corner of the eye was stimulated with electrode arrangements 2 and 3, which was reflected in the presentation position of the phosphenes.
Figure 7d shows the results of a verification experiment using electrode arrangement 4, and it can be seen that phosphenes were presented approximately on the left side of the visual field at fixation points 1 to 7. Some subjects were stimulated around the Ora Serrata as, with electrode arrangement 1, the phosphene was presented on the right side of the visual field. Some subjects were stimulated around the center of the eye, which was originally intended to be stimulated by electrode arrangement 3, as with electrode arrangement 1. Therefore, by adjusting the electrode arrangement position of the relevant subjects, phosphenes can be presented on the left side of the visual field.
With both electrode arrangements, there is no significant change in the presentation position of the phosphenes when the subjects are gazing at the central visual field. However, from fixation point 6, where eye movement exceeds 15 deg, the presentation position of the phosphenes appears to differ in each subject. In addition, it can be seen that phosphenes were generally observed to the right at odd fixation points after fixation point 8 in
Figure 7a,b, which used electrode arrangements that stimulate the right eye. These results were attributed to the fact that, at odd fixation points, the retina controlling the right side of the visual field was exposed to the anterior side by moving the eye to the right and was directly stimulated. In addition, it was widely observed from the left to the center at even fixation points. The even fixation points were trials in which the eyeball was moved to the left, and as mentioned in
Section 2.1, the retina on the temporal side of the right eye controls the left side of the visual field but the nose blocks the view, and so the peripheral vision in the left visual field cannot be recognized. This makes it difficult to recognize how far the phosphenes moved to the left of the visual field, and it is thought that they were widely observed from the left to the center.
It can be seen that phosphenes were generally observed to the left at even fixation points after fixation point 8 in
Figure 7c,d, which used electrode arrangements that stimulated the left eye. These results are because, at even fixation points, the retina controlling the left side of the visual field was exposed to the anterior side by moving the eyeball to the left and was directly stimulated. Additionally, it was widely observed from the right to the center at odd fixation points. As with the right eye, the visual retina on the temporal side of the left eye controls the right side of the visual field, but because the nose blocks the field of vision, it is unable to recognize the peripheral vision on the right side of the visual field. This makes it difficult to recognize how far the phosphenes moved to the right of the visual field, and it is thought that they were observed widely from the right to the center.
Next, the quantitative evaluation of the result of the verification experiment is mentioned.
Figure 8 shows the average of the gravity point coordinates of the circles, indicating the presentation position of phosphenes drawn by all subjects when electrode arrangement 1 was used. Similarly,
Figure 9,
Figure 10 and
Figure 11 show the average gravity point coordinates of the phosphene presentation positions for electrode arrangements 2, 3, and 4, respectively. In
Figure 8a,
Figure 9a,
Figure 10a and
Figure 11a, the horizontal and vertical axes show the size of the images drawn by the subjects, indicating the phosphene presentation positions, 0 to 2200 pixels and 0 to 1800 pixels, respectively. In
Figure 8b,
Figure 9b,
Figure 10b and
Figure 11b, the vertical axes were enlarged from the images drawn by the subjects to 0 to 600 pixels, indicating the phosphene presentation positions. Each point shows the average phosphene presentation positions at each fixation point, and the average phosphene presentation positions for fixation points 1 to 17 are connected by lines in numerical order. The lines connecting each point show a dark blue to yellow gradation from fixation points 1 to 17.
For all electrode arrangements, the phosphene presentation positions also fluctuate significantly as the fixation point moves toward the peripheral visual field.
Figure 12,
Figure 13,
Figure 14 and
Figure 15 show the average phosphene presentation positions at fixation points 1 to 7 when electrode arrangements 1, 2, 3, and 4 were used, respectively. Comparing
Figure 8 and
Figure 12, the fluctuation in the presentation position of the phosphene has become smaller. Similarly, comparing
Figure 9 and
Figure 13,
Figure 10 and
Figure 14, and
Figure 11 and
Figure 15, it is clear that the fluctuation in the presentation position of the phosphene has become smaller. Therefore, it was shown that the fluctuation in the presentation position of the phosphene is small within the range of eye movement of ±15 deg. The right and left ends of the phosphene presentation position within a range of ±15 deg of eye movement are highlighted in
Figure 12,
Figure 13,
Figure 14 and
Figure 15. The x-coordinates of these highlighted points were used to calculate the range of phosphene fluctuation. When eye movement was within a range of ±15 deg, the fluctuation in the phosphenes’ presentation position was insignificant. The difference in the horizontal axis fluctuation was 317.08 pixels for electrode arrangement 1, 543.75 pixels for electrode arrangement 2, 574.18 pixels for electrode arrangement 3, and 443.89 pixels for electrode arrangement 4. In
Section 3.2, it was mentioned that, if the fluctuation in the presentation position of the phosphenes is greater than 733 pixels, which is 2200 pixels divided into thirds, it can be interpreted as a significant change in the presentation position of the phosphenes. It was found that, for all electrode arrangements, when eye movement was within a range of ±15 deg, the fluctuation was smaller than 733 pixels. Therefore, when eye movement was within a range of ±15° for all electrode arrangements, the phosphenes did not show a significant change in the presentation position.
5. Discussion
This section discusses the position of phosphenes for subjects in whom phosphenes were presented in an unintended direction in the results of the verification experiments. The effect on the transition of the phosphene presentation position for all subjects, except those who observed phosphenes in an unintended direction, is also shown by excluding the results of these specific subjects. In addition, the safety of a walking assistive device using phosphenes for visually impaired people is discussed, taking into account the internal structure of the eyeball described in
Section 2.1, the angle of eye movement during walking reported in the related study described in
Section 2.2, and the change in the presentation position of phosphenes due to eye movement obtained in the verification experiment of this study.
Table 1 shows the presentation position of phosphenes observed by the subjects when using electrode arrangements 1 and 4. Electrode arrangement 1 was used to present phosphenes to the right side of the visual field, and electrode arrangement 4 was used to present phosphenes to the left side of the visual field. However, a previous study has stated that unintended areas may be stimulated depending on the shape of the subject’s face [
4]. The electrode arrangement used in this study was based on the electrode arrangement reported in previous studies [
4]. However, the electrode arrangements were not calibrated for each subject in this experiment. As a result, it is likely that some subjects experienced unintended phosphene presentations, as shown in
Table 1.
Figure 16a shows the transition of the phosphene presentation position for all sub-jects, excluding the results of the subjects who did not experience phosphene presentation to the right of the visual field when using electrode arrangement 1, as shown in
Table 1. Similarly,
Figure 16b shows the transition of the phosphene presentation position for all subjects, excluding the results of the subjects who did not experience phosphene presentation to the left of the visual field when using electrode arrangement 4, shown in
Table 1. At fixation points 1 to 7, it can be seen that the phosphene is presented to the right in
Figure 16a and the left in
Figure 16b. As shown in
Table 1, some subjects experienced phosphene presentation not only to the right of the visual field when using electrode arrangement 1 but also in the center or left side. Similarly, when electrode arrangement 4 was used, some subjects observed phosphenes not only on the left side of the field of view but also on the center or right side. Thus,
Figure 16a shows that phosphenes were presented in the center and left side of the visual field, but the number of such phosphenes is clearly smaller than that in
Figure 7a, which is the verification result. Similarly, in
Figure 16b, phosphenes are seen to be presented in the center and right side of the visual field, but the number of such phosphenes is clearly smaller than that in
Figure 7d, which is the verification result.
Furthermore, under the same subject conditions, the average of the gravity points of the presentation positions of the phosphenes drawn by the subjects was calculated, and only the range of fixation points 1 to 7 is shown in
Figure 17 for electrode arrangement 1 and
Figure 18 for electrode arrangement 4. The extent to which the presentation position of the phosphenes does not fluctuate due to eye movement is discussed in comparison to the verification results.
Comparing
Figure 12 and
Figure 17 when electrode arrangement 1 was used, the distribution shown in
Figure 17 was to the right of the average gravity points of the phosphene presentation positions shown in
Figure 12. In
Figure 17, the fluctuation of the phosphene presentation positions was less than that in
Figure 12. The difference in the horizontal axis fluctuation was 317.08 pixels in
Figure 12; however, it was clearly smaller at 241.79 pixels in
Figure 17. Similarly, comparing
Figure 15 and
Figure 18 when electrode arrangement 4 was used, the distribution shown in
Figure 18 is to the left of the average center of gravity of the phosphene presentation positions shown in
Figure 15. In
Figure 18, the fluctuation of the phosphene presentation positions is smaller than that in
Figure 15, and the difference in the horizontal axis fluctuation was 443.89 pixels in
Figure 15; however, it was clearly smaller at 353.31 pixels in
Figure 18. In
Section 3.2, it was mentioned that, if the fluctuation in the presentation position of the phosphenes is greater than 733 pixels, which is 2200 pixels divided into thirds, it can be interpreted as a significant change in the presentation position of the phosphenes. Therefore, it was suggested that, if the optimal electrode arrangement for the subject was selected so that the phosphene could be presented in the intended direction, the fluctuation of the phosphene presentation position within the range of eye movement of ±15 deg would not be a safety issue.
Considering the results of the related study on eye movements during walking, as shown in
Section 2.2, the safety of the walking assistive device for the visually impaired using phosphenes is discussed.
The assistive device in this study was aimed at visually impaired people with peripheral damage to the visual pathway, including those with retinitis pigmentosa, which was the subject of the related study [
13] mentioned in
Section 2.2. The reason why retinitis pigmentosa patients can be targeted in this study is that electrical stimulation from electrodes placed on the face stimulates the retinal ganglion cells and amacrine cells, but not the rod and cone cells that are damaged by retinitis pigmentosa, except when the retinal photoreceptors are exposed to the anterior side due to eye movement [
3,
17,
18].
This suggests that the current flowing through the anterior side stimulates ganglion cells and amacrine cells, and it is possible to present phosphenes by ocular stimulation to patients with retinitis pigmentosa.
As mentioned in
Section 2.2, the eye movement of patients with retinitis pigmentosa during walking was within 2/3 of their normal visual field [
13]. In addition, in experiments with sighted subjects, eye movement during walking were generally considered to be within 15 deg [
12].
When considering this information and the actual phosphene presentation position during eye movement reported in the verification experiment of this study, it can be concluded that the presentation position of the phosphene does not change significantly within the range of eye movement during walking reported in related studies [
12,
13], and that this result does not threaten the safety of walking assistive devices for visually im-paired people using phosphenes.
In addition, as shown in
Section 2.1, the angles required for the right eye to expose the Ora Serrata on the anterior side through eye movement are 77π/300 rad and 17π/60 rad on the left and right, respectively. In degrees, these are 18.6 deg and 11 deg, respectively. An angle of 11 deg is a small eye movement compared to the ±15 deg that was the focus of this study, and if the change in the presentation position of the phosphene due to the anterior exposure of the Ora Serrata was significant, the safety of the phosphene walking assistive device would be impaired. For the Ora Serrata when looking at the presentation position of phosphene drawn by the subject in
Figure 16, there is variation at fixation points 4 and 6 when using electrode arrangement 1 compared to fixation points 1, 2, and 3. However, as mentioned above in this section, when looking at the average value of the gravity points of the presentation position of phosphene shown in
Figure 17 and
Figure 18, it is clear that the variation is within a range that does not cause problems under the premise of presenting the phosphene in three directions of the visual field.
Because even if the Ora Serrata is exposed to the anterior side by moving the eyeball 11deg, there are few retinal photoreceptors distributed near the Ora Serrata, and the stimulus is not effectively delivered.
From the above, the effect of the change in the presentation position of phosphene due to eye movement during walking on the safety of the walking assistive device for visually impaired people using phosphenes is extremely small.